Midostaurin and Valacyclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Midostaurin (midostaurin) and Valacyclovir (valacyclovir hydrochloride). Common drug interactions include anaemia among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Midostaurin and Valacyclovir. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Midostaurin?

Midostaurin has active ingredients of midostaurin. eHealthMe is studying from 1,137 Midostaurin users. Check the latest studies of Midostaurin.

What is Valacyclovir?

Valacyclovir has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. eHealthMe is studying from 42,107 Valacyclovir users. Check the latest studies of Valacyclovir.



On Aug, 07, 2026

25 people who take Midostaurin and Valacyclovir together, and have interactions are studied.

Midostaurin and Valacyclovir drug interactions.

What are the common drug interactions of Midostaurin and Valacyclovir, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  3. Epistaxis (bleed from the nose)
  4. Fall
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Hyperglycaemia (high blood sugar)
  7. Ketoacidosis (high concentrations of ketone bodies in blood)
  8. Nocardiosis (an infectious disease affecting either the lungs or whole body)
  9. Skin infection

male:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Skin infection
  4. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
  5. Acute myocardial infarction (acute heart attack)
  6. Haemorrhage intracranial (bleeding within the skull)
  7. Arthralgia (joint pain)
  8. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  9. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
  10. Pancreatitis (inflammation of pancreas)

What are the common drug interactions of Midostaurin and Valacyclovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Haemorrhage intracranial (bleeding within the skull)
  3. Pneumonia

50-59:

  1. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Drug ineffective

60+:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. C-reactive protein increased
  3. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
  4. Acute myocardial infarction (acute heart attack)
  5. Anaemia (lack of blood)
  6. Arthralgia (joint pain)
  7. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
  8. Pancreatitis (inflammation of pancreas)
  9. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  10. Epistaxis (bleed from the nose)

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 16 people, 64.00%
  2. High Blood Pressure: 8 people, 32.00%
  3. Nausea (feeling of having an urge to vomit): 6 people, 24.00%
  4. Abdominal Distension: 5 people, 20.00%
  5. Arrhythmias (irregular heartbeat): 5 people, 20.00%
  6. Indigestion: 5 people, 20.00%
  7. Constipation: 3 people, 12.00%
  8. Dyslipidaemia (abnormal amount of lipids): 3 people, 12.00%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 12.00%
  10. Type 2 Diabetes: 3 people, 12.00%

* Approximation only. Some reports may have incomplete information.

Do you take Midostaurin and Valacyclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Midostaurin and Valacyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Midostaurin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Valacyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Midostaurin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valacyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on midostaurin and valacyclovir hydrochloride (the active ingredients of Midostaurin and Valacyclovir, respectively), and Midostaurin and Valacyclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: